HBV RNA in serum is an early predictor for sustained immune control following treatment with pegylated interferon alfa in patients with HBeAg negative chronic hepatitis B


Farag M., Campenhout M. V. , van Boemmel F., Rijckborst V., Cakaloglu Y., Ferenci P., ...Daha Fazla

International Liver Congress (ILC), Paris, Fransa, 11 - 15 Nisan 2018, cilt.68 identifier